Search For "remdesivir"
Jubilant launches Remdesivir in India for treatment of COVID-19
Updated : 1 day, 15 hours ago IST
Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment throug
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remde
Updated : 2 weeks, 2 days ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Mylan announces commercial launch of its Remdesivir under brand na
Updated : 2 weeks, 2 days ago IST
New Delhi/Bengaluru [India], July 20 (ANI): Pharmaceutical company Mylan on Monday announced the commercial launch of its Remdesivir under the brand name DESREM™ in India to address urgent, unmet needs amid COVID-19 pandemic.
Read More
Maharashtra: 7 arrested for black-marketing of Remdesivir in Mumba
Updated : 2 weeks, 3 days ago IST
Mumbai (Maharashtra) [India], July 19 (ANI): The Mumbai Crime Branch on Sunday said that seven people were arrested for alleged involvement in the black-marketing of Remdisvir, the drug being used for the treatment of hospitalised COVID-19 patients.
Read More
Hyderabad police arrest 7 people for black marketing COVID-19 drug
Updated : 2 weeks, 4 days ago IST
Hyderabad (Telangana) [India], July 18 (ANI): The Hyderabad Police arrested seven persons accused of illegally procuring and selling of COVID-19 antiviral drugs Covifor (Remdesivir) and Cipremi Injections, on Saturday.
Read More
Hyderabad: 8 held for illegally selling COVID-19 drugs
Updated : 3 weeks ago IST
Hyderabad (Telangana) [India], July 15 (ANI): Hyderabad Police has claimed to have busted an interstate black marketing gang for allegedly selling emergency drugs for COVID-19, and seized Rs 55,000 cash along with drugs worth over Rs 35 lakh. Eight people have been arrested by the police so
Read More
COVID-19: Indiscriminate use of Remdesivir and Tocilizumab can cau
Updated : 3 weeks, 4 days ago IST
New Delhi [India], July 11 (ANI): While the Central government has indicated drugs like Remdesivir and Tocilizumab as an "investigational therapies" for the treatment of hospitalized coronavirus patient, the Union health ministry has alarmed all states, union territories and medical college
Read More
No shortage of COVID-19 medicine in Goa, every patient treated as
Updated : 3 weeks, 4 days ago IST
Panaji (Goa) [India], July 11 (ANI): Goa Health Minister Vishwajit Rane on Friday said that the state has sufficient medicines to fight coronavirus and every patient is treated like a VIP.
Read More
Strict action will be taken against black marketeers of Remdesivir
Updated : 3 weeks, 5 days ago IST
Mumbai (Maharashtra) [India], July 10 (ANI): Maharashtra Home Minister Anil Deshmukh on Friday said that strict action will be taken against those involved in black marketing of Remdesivir and other medicine which are useful to treat COVID-19 patients.
Read More
DCGI instructs pharma giants manufacturing remdesivir to upload de
Updated : 3 weeks, 6 days ago IST
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug
Read More
COVID19: Top drug regulator directs states drug controller to be v
Updated : 4 weeks, 1 day ago IST
New Delhi [India], July 7 (ANI): The country's top drug regulator has directed all drug controller in the States and Union Territories to keep strict vigil to prevent the black marketing and sale of the anti-drug Remdesivir injection above the minimum retail price (MRP).
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800
Updated : 4 weeks, 1 day ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More